Here are the S-3 shelf registrations from P3 Health Partners Inc. Warrant (PIIIW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow PIIIW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PIIIW filings page.
P3 Health Partners Inc. (PIII) describes a proposed resale registration for up to 15,636,134 shares of Class A Common Stock issuable upon exercise of warrants. Selling stockholders may sell any, all or none of the shares from time to time after the registration statement becomes effective, at prices and through methods described in the prospectus. P3 is not selling shares itself and receives no proceeds from stockholder resales.
Assuming all outstanding Warrants are exercised for cash, P3 expects approximately $167.9 million; it expects net proceeds, if any, to fund continued growth and general corporate purposes. Warrant exercise would increase Class A shares outstanding and dilute existing holders. Class A shares outstanding were 4,015,604 as of October 12, 2026. The prospectus states management identified substantial doubt about P3's ability to continue as a going concern. It also describes cumulative preferred-stock dividend rates of 13.5%, 17.5% and 19.5% and says preferred stock ranks senior to common stock.